Delivery Order SPE2DB25D3404-SPE2DB25FUPGH
Award Date 7/14/25
Potential Completion Date 8/4/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for INGREZZA 80 mg capsules (30-count) on September 15, 2025, with completion targeted for October 6, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of involuntary movement disorders,...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a neurological medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order valued at $14.7K to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on August 25, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of INGREZZA 40 mg capsules (30-count packaging) with a ceiling value of $3,874.06. This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract. This non-set-aside award was issued on August 18, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a branded antipsychotic medication used to treat tardive dyskinesia, a neurological movement...
- The Defense Logistics Agency awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with no set-aside designation, competitively awarded with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. INGREZZA is an...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed-price arrangement valued at $4,027.70. This non-competitive delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of...